Lamond David - Insider Non-Derivative Transactions at Quince Therapeutics, Inc. (QNCX) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Dec 14, 2023, Lamond David's relationship to Quince Therapeutics, Inc. (QNCX) is Director, and currently has 2,347,545 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other QNCX insiders.

Data Source: SEC.
Lamond David - Insider Non-Derivative Transactions of QNCX Common Stock
Lamond David - Insider Non-Derivative Transactions at QNCX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Dec 15, 2023 P -- (Common Stock) 22627 1.04 2347545
Dec 14, 2023 P -- (Common Stock) 22627 1 2324918
Dec 13, 2023 P -- (Common Stock) 300 1 2279964
Dec 13, 2023 P -- (Common Stock) 22327 1.02 2302291
Dec 8, 2023 P -- (Common Stock) 19123 1.01 2279664
Dec 7, 2023 P -- (Common Stock) 19123 1.02 2260541
Dec 6, 2023 P -- (Common Stock) 19123 1.01 2241418
Dec 2, 2023 P -- (Common Stock) 14378 0.94 2222295
Dec 1, 2023 P -- (Common Stock) 14378 0.9 2207917
Nov 30, 2023 P -- (Common Stock) 14378 0.98 2193539
Sep 1, 2023 P -- (Common Stock) 41026 1.32 2179161
Aug 31, 2023 P -- (Common Stock) 41026 1.31 2138135
Aug 18, 2023 P -- (Common Stock) 24766 1.29 2097109
Aug 17, 2023 P -- (Common Stock) 117348 1.29 2072343
Aug 16, 2023 P -- (Common Stock) 107886 1.32 1954995